During early stages of pulmonary vascular development, angiogenesis, vasculogenesis and lymphangiogenesis play major roles in the establishment of the functional vascular and lymphatic networks. VEGF-D expression is strongly expressed in developing lung mesenchyme (2) and functions by binding the endothelial cell tyrosine kinase VEGFR-3. VEGF-D has been shown to induce lymphangiogenesis and the tumor metastasis in in vitro and in transgenic models. Signaling through VEGFR-3 has been demonstrated to induce lymphangiogenesis and maintenance of lymphatic vessels in vitro and in adult transgenic animals (4,6). However, there is no information on the role of VEGF-D in lung lymphangiogenesis. Pulmonary lymphatics are critical at birth for fluid clearance and normal lung function. Based on the known function of VEGFR-3 signaling and the unique pattern of expression of VEGF-D, we hypothesize that: VEGF-D is required for pulmonary lymphatic development and endothelial cell differentiation from a vascular to lymphatic lineage.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
5F31GM066473-02
Application #
6612719
Study Section
Minority Programs Review Committee (MPRC)
Program Officer
Toliver, Adolphus
Project Start
2002-08-01
Project End
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
2
Fiscal Year
2003
Total Cost
$28,627
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Mallory, Bradford P; Mead, Timothy J; Wiginton, Diane A F et al. (2006) Lymphangiogenesis in the developing lung promoted by VEGF-A. Microvasc Res 72:62-73